Internal Medicine·New York, NY

New York Presbyterian Hospital (Columbia Campus)

Signal lift3%39%+36 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
248–275
p10 – p90
Sample N
2,622
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
2.1%
55 of 2,622 applicants
01Cohort funnelthis cycle
N = 2,622
Applied
2,622
100.0%
Invited
346
13.2%
Class size
55
2.1%
02Away rotation impact
+27pp lift
Non-rotators
13%
344 of 2,617
Rotators
40%
2 of 5
Interview lift
+27pp
vs not rotating

Of 5 prior-cycle rotators, 40% got an interview vs 13% for the wider applicant pool here. Rotation appears to materially shift interview odds at this program.

J-1 visaAny graduation yearCategoricalResearchAcademic/Clinician Educator
Your fitNew York Presbyterian Hospital (Columbia Campus) Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at New York Presbyterian Hospital (Columbia Campus) Program

Create free account

Who to contact

Interview day

From notes past applicants shared, 2023-24 to 2026-27

The day
Full day, 10:15 AM to 5 PM
2026-27
Style
Conversational
2025-26
After the day
Most liked it more
6 more, 2 the same, 1 less · 2025-26
Gift
None
2023-24
What they asked · 2025-26
  • Tell me about yourself.
  • What are your future goals?
  • What are you looking for in a program?
  • What were your best and worst rotations?
Worth knowing
  • Pseudo 4+2: a heavy four-week block followed by a lighter two-week block. 2026-27
  • ICU call is 28 hours every fourth day, front-loaded in intern year. 2026-27
  • Moonlighting is allowed starting in PGY2. 2026-27
  • Residents are not unionized. 2026-27

Paraphrased from applicant notes. A tag shows once two notes mention it; the number is how many did.

Training sites2 hospitals · New York
  • 1
    NewYork-Presbyterian/Columbia University Irving Medical Center
    New York, NY
    Primary
  • 2
    New York Presbyterian Hospital
    New York, NY
    Sponsor
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK248 – 275
180205230255280

Level 2 CE data not available

Interview rates
US MD
24%
US DO
0%
US IMG
0%
Non-US IMG
0%
Signal rates
Gold
46%
Silver
30%
None
2%
Applicant origin
In-state
31%
Out-of-state
11%
Similar programs
01
Beth Israel Deaconess Medical Center ProgramBoston, MA
248–275
02
Mass General Brigham/Massachusetts General Hospital ProgramBoston, MA
249–275
03
Stanford Health Care-Sponsored Stanford University ProgramStanford, CA
250–274
04
Mass General Brigham/Brigham and Women's Hospital ProgramBoston, MA
246–275
05
Mayo Clinic College of Medicine and Science (Rochester) ProgramRochester, MN
248–273
Interview prepInternal Medicine
specialtyWhy internal medicine over family medicine?★ common
specialtyAre you interested in subspecializing? Which fellowship?★ common
clinicalDescribe a complex diagnostic case you've worked through.★ common
clinicalHow do you approach a patient with multiple comorbidities?
clinicalWhat's your approach to evidence-based medicine?
programAcademic vs community — what setting do you prefer?
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesInternal Medicine · 25-26
ResMatch ↗Discord ↗
Related
View all Internal Medicine programsCalculate match probabilitySignal strategy advisor
Save this program

Add New York Presbyterian Hospital (Columbia Campus) to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Internal Medicine.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.